Recent data has shown that TCF7L2 could activate PI3K/AKT pathway in numerous diseases, such as prostate cancer and T2DM [19], which might also explain why TCF7L2 confers so many functions in the incidence and development of metabolic diseases. Here, TCF7L2 is linked to prostate cancer.